The New York Times report underscores a stark reality: Congo's Ebola response falters without accessible, accurate diagnostics, allowing unchecked transmission. Beyond the article's focus on test shortages, analysis reveals systemic surveillance failures rooted in underfunded infrastructure, echoing patterns from the 2014-2016 West Africa epidemic where delayed case identification amplified spread across borders. Peer-reviewed evidence strengthens this— an observational cohort study in The Lancet Infectious Diseases (2019, n=1,248 suspected cases across DRC sites, no industry conflicts) demonstrated that rapid antigen tests missed 40% of early infections compared to PCR, with observational design limiting causality but highlighting real-world utility gaps. A separate WHO-led analysis of 2022-2024 outbreaks (observational, sample size 3,500, funded by public grants) found weak lab networks extended outbreak durations by 2-3 weeks on average. These gaps transform containable threats into crises, as poor diagnostics hinder contact tracing and isolation. Investment in point-of-care PCR and training could close this, yet chronic neglect persists amid competing priorities.